Cubist to Present at December Investor Conference

  Cubist to Present at December Investor Conference

Oppenheimer Healthcare Conference 2012

Business Wire

LEXINGTON, Mass. -- December 03, 2012

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company
management will discuss Cubist’s business activities and financial outlook at
the Oppenheimer 23^rd Annual Healthcare Conference in December 2012. Details
are below.

   PRESENTER:   Steve Gilman, EVP and Chief Scientific Officer
      EVENT:         Oppenheimer 23^rd Annual Healthcare Conference
      DATE:          Thursday, December 13, 2012
      TIME:          10:35 a.m. Eastern Time
      LOCATION:      The Waldorf Astoria, New York City
      WEBCAST:       Live audio with slide webcast can be accessed here.
                     

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
research, development, and commercialization of pharmaceutical products that
address significant unmet medical needs in the acute care environment. Cubist
is headquartered in Lexington, Mass. Additional information can be found at
Cubist’s website.

Contact:

Investors:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
Media:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com
 
Press spacebar to pause and continue. Press esc to stop.